Looking at Liposomal CBD Studies
An early relevant study doesn’t look at liposomes. However, the research by Lodzki M., published in the Journal of Controlled Disease in December 2003, made an exciting discovery in the use of transdermal CBD. The team used ethosomes. These are delivery carriers with similarities to liposomes. They enable drugs to go deep into the skin’s layers.
Lipsomal CBD in Rheumatic Disease
The study involved administering CBD to mice with rheumatic diseases. They noticed a significant accumulation of CBD in the muscle and skin. A massive reduction in inflammation accompanied it. The conclusion was that CBD was an effective anti-inflammatory treatment when delivered via protective capsules.
Lipsomal CBD bioavailability up by almost 400%
Neo-Cure, in conjunction with the University of Nottingham in England, published the results of a fascinating study in 2019. It looked at the bioavailability of CBD in a liposomal formulation compared to ‘traditional’ oil solutions. The research suggested that CBD liposomes boosted bioavailability by almost 400%! It was a tiny sample size of just nine volunteers, however.
What is CBD and Liposomal CBD?
CBD is a cannabinoid derived from the cannabis plant, which has the potential to provide a beneficial effect on neurological disorders and many other conditions. This is due to the body’s own endocannabinoid system (ECS), which features receptor sites that can be stimulated by phytocannabinoids like CBD. However, CBD is non-psychoactive and non-toxic and therefore doesn’t impact regular functioning. For that reason, it is considered a viable dietary supplement for most of the population.
After extensive and innovative research, Cibdol concluded in 2018 that adding liposomes to CBD products not only enables quicker absorption of CBD in the body, but also results in a higher percentage of CBD delivered to the blood compared to other carriers, such as olive oil. This led to the development of a completely new range of products.
How do Liposomes help Liposomal CBD absorption?
The new product line is characterised by the use of liposomes as carriers. A liposome is a sort of protective bubble that encapsulates CBD molecules. Using liposomes as carriers, CBD is delivered to the blood up to four times faster than traditional carriers. The percentage of CBD that reaches the blood is increased as well. Conversely, when using olive oil, a higher percentage of CBD is degraded by digestive enzymes in the stomach and never ends up in the blood.
Lipsomal CBD on SelectKana
To view our range of CBD products on Select Kana, view our shop by clicking HERE